This message was sent to ##Email##
To advertise in this publication please click here
|
|
|
.SOCIETY NEWS
Call for AST Board Nominations
AST
The AST is now accepting nominations for its 2021 Board of Directors. If you are interested in joining the AST Board, or know someone who is, we encourage you to submit your nomination. Learn more about the election process here.
|
|
The 2020 COP Donation Derby is Here
AST
We just launched the 2020 COP giving contest: The Donation Derby. Watch this race, as the COPs compete for two prizes and fundraise for their upcoming initiatives. All donations made by COP members until the end of the year will count toward this contest, so be sure to check it out today.
|
|
|
|
 |
|
Watch kidney transplant patients talk about their diagnoses and the importance of communication with their doctors and transplant teams. For these patients, switching therapies made sense.
See the video
![]()
|
|
COP Members: Renew by December 31
AST
COP members interested in self-nominating for an executive committee position must renew their AST membership by December 31, 2020. To renew, log in to your account to pay your invoice. If you need assistance or have further questions, please email info@myAST.org.
|
|
FAST Applications Open
AST
The Fellow of the American Society of Transplantation (FAST) designation application is now open to all members who meet the eligibility criteria. Instructions for the application can be found here. The deadline to apply is January 19, 2021. Don't miss out on joining this prestigious program and be recognized for your contributions to transplantation.
|
|
|
|
 |
|
- RELiZORB mimics the function of pancreatic lipase and delivers absorbable fats to your patients.
- Indicated for use in pediatric patients (ages 5 years and above) and adult patients to hydrolyze fats in enteral formula.
Learn more at relizorb.com REL20-310
|
|
Introducing the Living Donor Circle of Excellence
AST
The AST is proud to introduce the Living Donor Circle of Excellence program! The vision for this program was inspired by the need to increase living organ donation by removing financial barriers donors sometimes encounter. Today, many employers do not offer any kind of compensation to an employee recovering from donating an organ. The Circle aims to change that. By recognizing companies who support living donation through providing salary support post-surgery, the AST envisions more people will consider this altruistic act.
|
|
|
|
COVID-19 and Transplantation: AJT Articles
AST
In the interest of facilitating patient care and advancing science and ensuring that accurate knowledge and experience is available to all during this current time of crisis, AJT has been expediting review of all papers dealing with COVID-19, as well as making them free to access for all.
|
|
AST Research Network
AST
The AST Research Network is now accepting applications for its annual career development grants cycle! The purpose of these grants is to foster the training of early career investigators who have the potential to contribute to transplant science/immunobiology and/or treatment of transplant recipients. The grants encourage continued commitment of high-quality applicants to their careers in transplantation. Applications are accepted in basic, clinical, and translational research.
|
|
| |
Veloxis Pharmaceuticals
Did you know there’s a transplant support system to help patients and providers with best-in-class assistance and resources? This ongoing support system assists with benefit investigation, prior authorization assistance, coordination with specialty pharmacies, prescription fulfillment navigation, and CoverMyMeds® access. There’s also a $0 co-pay card to overcome financial barriers.
Find out more
|
|
|
.UPCOMING EDUCATION EVENTS
|
Labs@HOME is a mobile phlebotomy in-home blood draw service to aid in specimen collection directly from a patient's home. Clinicians can order and customize a number of infectious disease and transplant-relatedtesting remotely
|
|
|
|
|
Thousands of industry professionals subscribe to association news briefs, which allows your company to push messaging directly to their inboxes and take advantage of the association's brand affinity.
Connect with Highly Defined Buyers and Maximize Your Brand Exposure
|
|
|
|
|
.TRANSPLANT NEWS
The Impact of Multi-Organ Transplant Allocation Priority on Wait-Listed Kidney Transplant Candidates
American Journal of Transplantation
Kidney‐Alone Transplant (KAT) candidates may be disadvantaged by the allocation priority given to multi‐organ transplant (MOT) candidates. This study identified potential KAT candidates not receiving a given kidney offer due to its allocation for MOT. Using the OPTN database, we identified deceased donors from 2002‐2017 that had one kidney allocated for MOT and the other kidney allocated for KAT or simultaneous pancreas‐kidney transplant (SPK) (n=7,378).
|
|
Liver Transplantation in the United States During the COVID-19 Pandemic: National and Center-Level Responses
American Journal of Transplantation
COVID‐19 has profoundly affected the American health care system; its effect on the liver transplant (LT) waitlist based on COVID‐19 incidence has not been characterized. Using SRTR data, we compared observed LT waitlist registrations, waitlist mortality, deceased donor LTs (DDLT), and living donor LTs (LDLT) 3/15/2020‐8/31/2020 to expected values based on historical trends 1/2016‐1/2020, stratified by statewide COVID‐19 incidence.
|
|
|
|
Detection of SARS-CoV-2 Antibodies in Kidney Transplant Recipients
Journal of the American Society of Nephrology
In this study, we analyze the seroprevalence of SARS-CoV-2 antibodies in a transplant population. In order to ensure the accuracy of the seroprevalence rate, we also evaluate the performance of different serologic assays within this patient cohort.
|
|
Optimization of De Novo Belatacept-Based Immunosuppression Administered to Renal Transplant Recipients
American Journal of Transplantation
Kidney transplant recipients administered belatacept‐based maintenance immunosuppression present with a more favorable metabolic profile, reduced incidence of de novo donor‐specific antibodies (DSAs), and improved renal function and long‐term patient/graft survival relative to individuals receiving calcineurin inhibitor (CNI)‐based immunosuppression. However, the rates and severity of acute rejection (AR) are greater with the approved belatacept‐based regimen than with CNI‐based immunosuppression.
|
|
HLA and AB0 Polymorphisms May Influence SARS-CoV-2 Infection and COVID-19 Severity
Transplantation
SARS-CoV-2 infection is heterogeneous in clinical presentation and disease evolution. To investigate whether immune response to the virus can be influenced by genetic factors, we compared HLA and AB0 frequencies in organ transplant recipients and waitlisted patients according to presence or absence of SARS-CoV-2 infection.
|
|
|
|
|
7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063
|
